|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Current assets: | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Short-term marketable securities | ||||||||||||||||
| Accounts receivable—net of allowance of $871 and $1,092 at December 31, 2019 and 2018, respectively | ||||||||||||||||
| Prepaid expenses | ||||||||||||||||
| Deferred commissions | ||||||||||||||||
| Other current assets | ||||||||||||||||
| Total current assets | ||||||||||||||||
| Property and equipment, net | ||||||||||||||||
| Right-of-use assets | ||||||||||||||||
| Goodwill | ||||||||||||||||
| Intangible assets, net | ||||||||||||||||
| Noncurrent prepaid expenses | ||||||||||||||||
| Deferred commissions, net of current portion | ||||||||||||||||
| Other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| Current liabilities: | ||||||||||||||||
| Accounts payable | ||||||||||||||||
| Accrued liabilities | ||||||||||||||||
| Deferred rent | ||||||||||||||||
| Lease liabilities | ||||||||||||||||
| Deferred revenue | ||||||||||||||||
| Total current liabilities | ||||||||||||||||
| Deferred revenue, net of current portion | ||||||||||||||||
| Lease liabilities, net of current portion | ||||||||||||||||
| Deferred rent, net of current portion | ||||||||||||||||
| Warrant liability | ||||||||||||||||
| Other long-term liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||
| Common stock, par value of $0.0001 per share; 200,000 shares authorized as of December 31, 2019 and 2018; 38,257 shares issued and outstanding as of December 31, 2019; 35,386 shares issued and outstanding at December 31, 2018 | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||
Loading...
